Hester Biosciences Limited (NSE:HESTERBIO)

India · Delayed Price · Currency is INR

1,419.40

+53.80 (3.94%)

Apr 2, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Poultry Healthcare	1.67B	1.45B	1.41B	1.72B	1.56B
Poultry Healthcare Growth	15.29%	2.78%	-17.76%	9.83%	30.00%
Animal Healthcare	1.44B	1.33B	1.14B	631.75M	578.81M
Animal Healthcare Growth	8.41%	16.09%	80.67%	9.15%	-8.01%
Others	-	267.89M	88.69M	-	-
Others Growth	-	202.05%	-	-	-
Petcare	-	-	17.67M	-	-
Total	3.11B	3.05B	2.66B	2.35B	2.14B
Total Growth	2.15%	14.45%	13.23%	9.65%	16.95%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
outside India	501.54M	653.76M	491.69M	448.29M	432.26M
outside India Growth	-23.28%	32.96%	9.68%	3.71%	27.14%
India	2.61B	2.39B	2.17B	1.90B	1.71B
India Growth	9.11%	10.26%	14.06%	11.15%	14.63%
Total	3.11B	3.05B	2.66B	2.35B	2.14B
Total Growth	2.15%	14.45%	13.23%	9.65%	16.95%

Source: S&P Global Market Intelligence.